SCHEMBL17037302

SCHEMBL17037302

N#Cc1ccc(-c2cc3c(-c4ccc(-c5ccc6ccc7cccc8ccc5c6c78)cc4)nc4ccccc4c3c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.40
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ATM Q13315 1/20 0.37
ABCG2 Q9UNQ0 3/20 0.36
ABCB1 P08183 1/20 0.36
CYP1A2 P05177 3/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
SLC22A12 Q96S37 2/20 0.36
ALDH1A1 P00352 4/20 0.36
LMNA P02545 2/20 0.36
THRB P10828 1/20 0.36
ALOX5 P09917 1/20 0.35
AKT1 P31749 1/20 0.34
GRM2 Q14416 1/20 0.34
PDPK1 O15530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17037300 0.94 ADORA2A (0.40) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL17034903 0.90 CYP1A2 (0.42) ADORA2AMEN1KMT2AATMCYP1A2
SCHEMBL17302733 0.86 AKT1 (0.36) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL17302729 0.86 ADORA2A (0.37) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL17037346 0.86 CA1 (0.36) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL20967864 0.84 ALOX5 (0.47) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL17302745 0.83 CYP1A2 (0.37) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL17037303 0.83 ABCG2 (0.48) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL20967898 0.82 ALOX5 (0.40) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL17034924 0.82 CYP11B1 (0.45) ABCG2ALDH1A1LMNAMAPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ADORA2A 4650/4885MEN1 476/4885KMT2A 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.